Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8985197rdf:typepubmed:Citationlld:pubmed
pubmed-article:8985197lifeskim:mentionsumls-concept:C0019682lld:lifeskim
pubmed-article:8985197lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:8985197lifeskim:mentionsumls-concept:C0242648lld:lifeskim
pubmed-article:8985197lifeskim:mentionsumls-concept:C1858460lld:lifeskim
pubmed-article:8985197lifeskim:mentionsumls-concept:C0205147lld:lifeskim
pubmed-article:8985197lifeskim:mentionsumls-concept:C0003241lld:lifeskim
pubmed-article:8985197lifeskim:mentionsumls-concept:C1422036lld:lifeskim
pubmed-article:8985197lifeskim:mentionsumls-concept:C0596260lld:lifeskim
pubmed-article:8985197lifeskim:mentionsumls-concept:C0913822lld:lifeskim
pubmed-article:8985197lifeskim:mentionsumls-concept:C0913823lld:lifeskim
pubmed-article:8985197pubmed:issue1lld:pubmed
pubmed-article:8985197pubmed:dateCreated1997-1-27lld:pubmed
pubmed-article:8985197pubmed:abstractTextMaternal antibodies against the envelope glycoprotein of human immunodeficiency virus type 1 (HIV-1) have previously been suggested to be important in influencing the rate of vertical transmission. In this study, serum antibody responses in mothers who did or did not transmit HIV-1 infection to their children were measured against the carboxy region of the transmembrane envelope glycoprotein gp41. Results indicate significantly higher binding reactivity of nontransmitter mothers compared with transmitters to three peptides spanning amino acids 771-810 and 841-856. In addition, high neutralization titers in maternal sera against HIV-1(MN) were associated with a nontransmission status. This is the initial report demonstrating a correlation between maternal antibody binding to epitopes within the carboxy region of gp41 envelope glycoprotein and lack of vertical transmission. Immunodetection that identifies antibodies to these regions in gp41 could therefore be considered a strategy to assess the risk of vertical transmission of HIV-1.lld:pubmed
pubmed-article:8985197pubmed:languageenglld:pubmed
pubmed-article:8985197pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8985197pubmed:citationSubsetAIMlld:pubmed
pubmed-article:8985197pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8985197pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8985197pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8985197pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8985197pubmed:statusMEDLINElld:pubmed
pubmed-article:8985197pubmed:monthJanlld:pubmed
pubmed-article:8985197pubmed:issn0022-1899lld:pubmed
pubmed-article:8985197pubmed:authorpubmed-author:WeinerD BDBlld:pubmed
pubmed-article:8985197pubmed:authorpubmed-author:WilliamsW VWVlld:pubmed
pubmed-article:8985197pubmed:authorpubmed-author:UgenK EKElld:pubmed
pubmed-article:8985197pubmed:authorpubmed-author:GoedertJ JJJlld:pubmed
pubmed-article:8985197pubmed:authorpubmed-author:SrikantanVVlld:pubmed
pubmed-article:8985197pubmed:authorpubmed-author:NelsonR PRPJrlld:pubmed
pubmed-article:8985197pubmed:issnTypePrintlld:pubmed
pubmed-article:8985197pubmed:volume175lld:pubmed
pubmed-article:8985197pubmed:ownerNLMlld:pubmed
pubmed-article:8985197pubmed:authorsCompleteYlld:pubmed
pubmed-article:8985197pubmed:pagination63-9lld:pubmed
pubmed-article:8985197pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:8985197pubmed:meshHeadingpubmed-meshheading:8985197-...lld:pubmed
pubmed-article:8985197pubmed:meshHeadingpubmed-meshheading:8985197-...lld:pubmed
pubmed-article:8985197pubmed:meshHeadingpubmed-meshheading:8985197-...lld:pubmed
pubmed-article:8985197pubmed:meshHeadingpubmed-meshheading:8985197-...lld:pubmed
pubmed-article:8985197pubmed:meshHeadingpubmed-meshheading:8985197-...lld:pubmed
pubmed-article:8985197pubmed:meshHeadingpubmed-meshheading:8985197-...lld:pubmed
pubmed-article:8985197pubmed:meshHeadingpubmed-meshheading:8985197-...lld:pubmed
pubmed-article:8985197pubmed:meshHeadingpubmed-meshheading:8985197-...lld:pubmed
pubmed-article:8985197pubmed:meshHeadingpubmed-meshheading:8985197-...lld:pubmed
pubmed-article:8985197pubmed:meshHeadingpubmed-meshheading:8985197-...lld:pubmed
pubmed-article:8985197pubmed:meshHeadingpubmed-meshheading:8985197-...lld:pubmed
pubmed-article:8985197pubmed:meshHeadingpubmed-meshheading:8985197-...lld:pubmed
pubmed-article:8985197pubmed:meshHeadingpubmed-meshheading:8985197-...lld:pubmed
pubmed-article:8985197pubmed:meshHeadingpubmed-meshheading:8985197-...lld:pubmed
pubmed-article:8985197pubmed:year1997lld:pubmed
pubmed-article:8985197pubmed:articleTitleVertical transmission of human immunodeficiency virus type 1: seroreactivity by maternal antibodies to the carboxy region of the gp41 envelope glycoprotein.lld:pubmed
pubmed-article:8985197pubmed:affiliationDepartment of Medical Microbiology and Immunology, University of South Florida College of Medicine, Tampa 33612, USA.lld:pubmed
pubmed-article:8985197pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8985197pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:8985197pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed